Bothell Bio Boost

Read the full article in Seattle Business, May 2011.

With a billion-dollar partner excited about early promise for yeast-grown antibodies, Alder Biopharmaceuticals is striding carefully toward the commercial launch of what may be a major rheumatoid arthritis drug.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.